Linezolid is Associated with Improved Early Outcomes of Childhood Tuberculous Meningitis

Abstract

Our data demonstrate that linezolid improves early outcome of childhood TBM. The low frequency of linezolid-associated adverse effects highlights the promising prospects of its use for treatment of childhood TBM.